Aspiration for the Future | Chanse Technology Invited to Attend the 2025 Drug Production Regulation Training by Chongqing Municipal Drug Administration|CHANSE

Training Overview

In response to the National Medical Products Administration’s policy guidance on deepening collaborative innovation in regulatory science, the special training themed Pharmaceutical Equipment Innovation and Regulatory Practice, co-organized by the Chongqing Municipal Drug Administration and Shanghai Pinju Technology Co., Ltd., was successfully held in Chongqing from April 21 to 25.

Training Highlights

With "whole-chain technological innovation in pharmaceutical production" as its core focus, this training covered key topics including advanced pharmaceutical process equipment, water and gas detection technologies, digital and intelligent transformation, and consumables management.

He Zhizhen, Chairman of Chanse Technology, was invited to the event. He provided the on-site regulatory personnel with a detailed briefing on the international and domestic development of solid dosage continuous manufacturing, the formulation of relevant standards and regulatory guidelines, continuous manufacturing modules, core technologies and implementation experience.

Subsequently, the training team of the 2025 Drug Production Regulation Training from the Chongqing Municipal Drug Administration visited Chanse Technology’s exhibition booth for exchange and learning activities.

As a leading enterprise in technological innovation and equipment R&D in the pharmaceutical sector, Chanse Technology showcased its core achievements at the booth, including intelligent pharmaceutical equipment and advanced pharmaceutical technology solutions, which drew the training team members to conduct in-depth observation and study.

Going forward, Chanse Technology will continue to deepen its two-wheel drive strategy of "technology R&D" and "regulatory practice". It will steadily increase innovation input in areas such as intelligent pharmaceutical equipment to drive whole-chain technological innovation; it will also deepen industry-university-research collaboration with drug regulatory authorities and industry organizations, and actively participate in the formulation and improvement of international and domestic technical standards and regulatory guidelines.

Returns

Next：Aspiration for the Future | Cutting-Edge Research on the Intelligentization of Traditional Chinese Medicine Processes and Equipment